Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Kozlowski

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The American Journal of Medicine|July 1, 1988
Poisoning with sustained-release verapamilJ H Kozlowski, J A Kozlowski, D Schuller
Health Physics|April 1, 1991
Measurements of contact currents in radiofrequency fieldsM A Stuchly, J A Kozlowski, S Symons, et al.
British Journal of Pharmacology|October 2, 2007
Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonistsC A Lunn, E-P Reich, J S Fine, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptorJ A Kozlowski, D B Lowe, H S Guzik, et al.
European Journal of Pharmacology|December 1, 2001
SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animalsG J Carey, W Billard, H Binch, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Metabolic stabilization of benzylidene ketal M(2) muscarinic receptor antagonists via halonaphthoic acid substitutionC D Boyle, S Chackalamannil, J W Clader, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The American Journal of Medicine|July 1, 1988
Poisoning with sustained-release verapamilJ H Kozlowski, J A Kozlowski, D Schuller
Health Physics|April 1, 1991
Measurements of contact currents in radiofrequency fieldsM A Stuchly, J A Kozlowski, S Symons, et al.
British Journal of Pharmacology|October 2, 2007
Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonistsC A Lunn, E-P Reich, J S Fine, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptorJ A Kozlowski, D B Lowe, H S Guzik, et al.
European Journal of Pharmacology|December 1, 2001
SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animalsG J Carey, W Billard, H Binch, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Metabolic stabilization of benzylidene ketal M(2) muscarinic receptor antagonists via halonaphthoic acid substitutionC D Boyle, S Chackalamannil, J W Clader, et al.
Pageof 1